Friday 6 November 2026 Export BRKR’s income statement to Excel — free account

Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue: +1.57%
EPS: −75.4%
Free cash flow: +278.7%
Total debt: −14.7%

Quarter to September 2026, against a year earlier

61.43 3.37 +5.80%

Follow BRKR

Alert me

Market cap: $8.9B
P/E: 0.0×
Fwd P/E: −412×
Dividend yield: 0.34%
F-score: 4/9
Altman Z: 2.43
Beneish M: −2.56
Dividend safety: 34/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Bruker Corporation 10-Q filed Aug 5, 2026

Fiscal Q2 2026 · Period ended Jun 30, 2026 · Filed Aug 5, 2026 · accepted 4:24 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed May 7, 2026: 1 modified